Biostasis Technologies, Inc. is a human cryopreservation R&D organization with the following objectives: (A) Experimental and theoretical research aimed at improving hypothermic tissue stabilization of legally deceased individuals and/or terminally ill patients, as permitted by law, for organ preservation, brain banking, anatomical donation, and human biostasis. (B) Publication and dissemination of research reports, protocols, and clinical standards to improve the practice and delivery of hypothermic tissue stabilization. (C) Education, training, and certification of medical professionals to conduct hypothermic tissue stabilization delivery services. (D) Assisting in the formation of regional hypothermic tissue stabilization delivery organizations and monitoring protocol compliance.
| Website | https://www.biostasistechnologies.org/ |
| Employees | 5 (2 on RocketReach) |
| Founded | 2022 |
| Industry | Biotechnology Research |
| Keywords | Cryopreservation, Tissue Preservation, Long-Term Preservation, Biopreservation, Scientific Research, Organ Preservation, Medical Research, Cellular Preservation, Biotechnology, Advanced Biotechnologies, Life Extension, Regenerative Medicine, Death Care, Future Medicine, Experimental Medicine |
| Competitors | Integra LifeSciences, Medtronic, Acelity, Organogenesis, Sientra, Inc., MediWound Ltd., CRYOLIFE LIMITED, Histogenics Corporation, California Cryobank Inc, HemaCare Corporation +34 more (view full list) |
Looking for a particular Biostasis Technologies employee's phone or email?
Max More is the Director of Communications of Biostasis Technologies.
2 people are employed at Biostasis Technologies.